Literature DB >> 17139502

CT-guided needle biopsies of bone and soft tissue tumors: a pathologist's perspective.

Edward F McCarthy1.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17139502     DOI: 10.1007/s00256-006-0244-8

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


× No keyword cloud information.
  3 in total

1.  CT-guided percutaneous core needle biopsy in deep seated musculoskeletal lesions: a prospective study of 128 cases.

Authors:  A Puri; V U Shingade; M G Agarwal; C Anchan; S Juvekar; S Desai; N A Jambhekar
Journal:  Skeletal Radiol       Date:  2005-12-09       Impact factor: 2.199

2.  Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours.

Authors:  Altay O Altuntas; John Slavin; Peter J Smith; Stephen M Schlict; Gerard J Powell; Sam Ngan; Guy Toner; Peter F M Choong
Journal:  ANZ J Surg       Date:  2005-04       Impact factor: 1.872

Review 3.  Core needle biopsy and fine-needle aspiration in the diagnosis of bone and soft-tissue lesions.

Authors:  A G Ayala; J Y Ro; C V Fanning; J P Flores; A W Yasko
Journal:  Hematol Oncol Clin North Am       Date:  1995-06       Impact factor: 3.722

  3 in total
  10 in total

1.  Image guided core needle biopsy of musculoskeletal lesions: are nondiagnostic results clinically useful?

Authors:  Manjiri M Didolkar; Megan E Anderson; Mary G Hochman; Julia G Rissmiller; Jeffrey D Goldsmith; Mark G Gebhardt; Jim S Wu
Journal:  Clin Orthop Relat Res       Date:  2013-07-17       Impact factor: 4.176

2.  Bone marrow biopsy: RNA isolation with expression profiling in men with metastatic castration-resistant prostate cancer--factors affecting diagnostic success.

Authors:  Charles E Spritzer; P Diana Afonso; Emily N Vinson; James D Turnbull; Karla K Morris; Adam Foye; John F Madden; Kingshuk Roy Choudhury; Phillip G Febbo; Daniel J George
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

3.  The diagnostic value of needle biopsy for musculoskeletal lesions.

Authors:  Ki-Sun Sung; Sung-Wook Seo; Min-Soo Shon
Journal:  Int Orthop       Date:  2009-08-05       Impact factor: 3.075

4.  CT-guided percutaneous biopsy of sclerotic bone lesions: diagnostic outcomes.

Authors:  I-Yuan Joseph Chang; Hakan Ilaslan; Murali Sundaram; Jean Schils; Naveen Subhas
Journal:  Skeletal Radiol       Date:  2017-12-07       Impact factor: 2.199

5.  Resected osteochondroma of the rib in an elderly patient.

Authors:  Ryutaro Kikuchi; Nobuya Mino; Tadashi Matsukura; Takashi Hirai
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-11-11

6.  Bone Subtraction Iodine Imaging for CT-Guided Bone Biopsy.

Authors:  Soichiro Okamoto; Hiroaki Ishii; Takao Hiraki
Journal:  Cardiovasc Intervent Radiol       Date:  2021-10-27       Impact factor: 2.740

7.  [Biopsies from bone and soft tissue sarcoma : a nationwide survey in Germany].

Authors:  F Pohlig; U Lenze; F W Lenze; H Mühlhofer; J Schauwecker; H Rechl; R von Eisenhart-Rothe
Journal:  Orthopade       Date:  2013-11       Impact factor: 1.087

8.  Osteosarcoma Manifesting Systemic Inflammation and Histological Features Mimicking Plasma Cell-type Castleman Disease.

Authors:  Shino Fujimoto; Tomoyuki Sakai; Hiroshi Kawabata; Nozomu Kurose; Sohsuke Yamada; Mariko Doai; Munetaka Matoba; Haruka Iwao-Kawanami; Takafumi Kawanami; Shuichi Mizuta; Toshihiro Fukushima; Hiroki Mizumaki; Masaki Yamaguchi; Yasufumi Masaki
Journal:  Intern Med       Date:  2019-06-07       Impact factor: 1.271

9.  Apparent diffusion coefficient (ADC): A potential in vivo biological surrogate of the incidentally discovered bone lesions at 3T MRI.

Authors:  M R Nouh; Ahmed Doweidar; Abdullah Mohie-Eddin Khalil
Journal:  Eur J Radiol Open       Date:  2021-11-25

10.  Percutaneous core needle biopsy versus open biopsy in diagnostics of bone and soft tissue sarcoma: a retrospective study.

Authors:  Florian Pohlig; Chlodwig Kirchhoff; Ulrich Lenze; Johannes Schauwecker; Rainer Burgkart; Hans Rechl; Ruediger von Eisenhart-Rothe
Journal:  Eur J Med Res       Date:  2012-11-01       Impact factor: 2.175

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.